Overview

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Status:
Terminated

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.

Phase:

Phase 2

Details

Lead Sponsor:

Solvay Pharmaceuticals